✦ LIBER ✦

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (Â±)-fluvastatin*

✍ Scribed by Transon, Catherine; Leemann, Thierry; Vogt, Nicole; Dayer, Pierre

Publisher: Nature Publishing Group
Year: 1995
Tongue: English
Weight: 802 KB
Volume: 58
Category: Article
ISSN: 0009-9236
DOI: 10.1016/0009-9236(95)90054-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro comparative inhibition profiles

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

✍ C. Transon; T. Leemann; P. Dayer 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 343 KB

Cytochrome P450 (CYP) 2J2 gene transfect

Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-κβ in hyperhomocysteinemia

✍ Karni S. Moshal; Darryl C. Zeldin; Srinivas D. Sithu; Utpal Sen; Neetu Tyagi; Mu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

## Abstract Hyperhomocysteinemia (HHcy) is associated with atherosclerotic events involving the modulation of arachidonic acid (AA) metabolism and the activation of matrix metalloproteinase‐9 (MMP‐9). Cytochrome P450 (CYP) epoxygenase‐2J2 (CYP2J2) is abundant in the heart endothelium, and its AA me

Eltrombopag, an oral thrombopoietin rece

Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis

✍ Julian Jenkins; Daphne Williams; Yanli Deng; David A. Collins; Valerie S. Kitche 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 301 KB

Mechanism of the decrease in catalytic a

Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis

✍ Eri Sano; Weihua Li; Hitomi Yuki; Xinli Liu; Tomomi Furihata; Kaoru Kobayashi; K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

## Abstract Cytochrome P450 (CYP) is deeply involved in the metabolism of chemicals including pharmaceuticals. Therefore, polymorphisms of this enzyme have been widely studied to avoid unfavorable side effects of drugs in chemotherapy. In this work, we performed computational analysis of the mechan

Inhibition of cholesterol synthesis ex v

Inhibition of cholesterol synthesis ex vivo and in vivo by fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase

✍ A. Yamamoto; S. Itoh; K. Hoshi; K. Ichihara 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 406 KB

Inhibition of the thrombogenic and infla

Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model

✍ Dardo E. Ferrara; Xiaowei Liu; Ricardo G. Espinola; Pier Luigi Meroni; Imad Abuk 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views